Effects of Serelaxin in Patients with Acute Heart Failure

Volume: 381, Issue: 8, Pages: 716 - 726
Published: Aug 22, 2019
Abstract
Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure.In this multicenter, double-blind, placebo-controlled, event-driven trial, we enrolled patients who were hospitalized for acute heart failure and...
Paper Details
Title
Effects of Serelaxin in Patients with Acute Heart Failure
Published Date
Aug 22, 2019
Volume
381
Issue
8
Pages
716 - 726
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.